Skip to content

ESD Home

TechCentury

Powered by

Engineering Society of Detroit Lawrence Technological University

Tag: Statin Drugs

Clinical Trials / Pharmaceuticals

Esperion sees positive results from final study on cholesterol-buster

ANN ARBOR — Esperion Therapeutics Inc. (Nasdaq: ESPR), the Ann Arbor-based pharmaceutical developer, announced positive results from the final Phase 3 test of its lead drug candidate, bempedoic acid. The …

Read the magazine:

TechCentury
Advertise or Contribute an Article
Lawrence Technological University

Subscribe to TechCentury.com

Top Posts

  • Liquid Web Bought Out By Chicago Firm; Founding CEO To Step Down
  • Esperion expands licensing deal with Daiichi Sankyo Group
  • Wayne State buys NextEnergy Center, launches innovation consortium
  • AT&T boosts 4G network coverage in UP
  • Priority Health provides members free access to personal health companion, ‘Brook’

Archives

Follow Us On

© The Engineering Society of Detroit   |   ABOUT